Topic
Pain assessment
About: Pain assessment is a research topic. Over the lifetime, 6245 publications have been published within this topic receiving 193026 citations. The topic is also known as: Pain Measurement.
Papers published on a yearly basis
Papers
More filters
Journal Article•
TL;DR: The development of the Brief Pain Inventory and the various applications to which the BPI is suited are described, being adopted in many countries for clinical pain assessment, epidemiological studies, and in studies of the effectiveness of pain treatment.
Abstract: Poorly controlled cancer pain is a significant public health problem throughout the world. There are many barriers that lead to undertreatment of cancer pain. One important barrier is inadequate measurement and assessment of pain. To address this problem, the Pain Research Group of the WHO Collaborating Centre for Symptom Evaluation in Cancer Care has developed the Brief Pain Inventory (BPI), a pain assessment tool for use with cancer patients. The BPI measures both the intensity of pain (sensory dimension) and interference of pain in the patient's life (reactive dimension). It also queries the patient about pain relief, pain quality, and patient perception of the cause of pain. This paper describes the development of the Brief Pain Inventory and the various applications to which the BPI is suited. The BPI is a powerful tool and, having demonstrated both reliability and validity across cultures and languages, is being adopted in many countries for clinical pain assessment, epidemiological studies, and in studies of the effectiveness of pain treatment.
4,423 citations
University of Rochester1, University of Washington2, Saint Louis University3, University of Toronto4, University of Texas MD Anderson Cancer Center5, University of Pennsylvania6, Johns Hopkins University7, Yale University8, National Institutes of Health9, Pfizer10, Food and Drug Administration11, NorthShore University HealthSystem12, Merck & Co.13, Allergan14, University of Copenhagen15, Purdue Pharma16, Celgene17, University of Oxford18, Élan19, GlaxoSmithKline20, Johnson & Johnson21, Duke University22, Oregon Health & Science University23, Endo International plc24, AstraZeneca25
TL;DR: A consensus meeting was convened by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) to provide recommendations for interpreting clinical importance of treatment outcomes in clinical trials of the efficacy and effectiveness of chronic pain treatments as discussed by the authors.
2,581 citations
TL;DR: NRSs are applicable for unidimensional assessment of PI in most settings, and whether the variability in anchors and response options directly influences the numerical scores needs to be empirically tested.
1,866 citations
TL;DR: Turk, Melzack, and Katz as discussed by the authors proposed the McGill Pain Questionnaire: Appraisal and current status to assess patients with chronic pain, and used it to measure the dimensions and stages of pain.
1,492 citations
Journal Article•
1,486 citations